Author:
Elgasim Mawahib Ahmed Elawad Abu,Suleiman Yousra Abdelmoniem,Abozaid Lobaina,Mohmmed Dlal Alser Hassan,Suliman Soha Saad Aldin Mohamad,Farh Duaa Hamd Abdulatif
Publisher
Scientific Research Publishing, Inc.
Reference15 articles.
1. Kumar, V., Abbas, A.K. and Aster, J.C. (2015) Robbins & Cotran Pathologic Basis of Disease. 9th Edition, Elsevier, Philadelphia.
2. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer
3. Lamb, C.A., Vanzulli, S.I. and Lanari, C. (2019) Hormone Receptors in Breast Cancer: More than Estrogen Receptors. Medicina (B Aires), 79, 540-545.
4. Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial
5. Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial